Avrupa Minerals Further Extends Massive Sulfide Mineralization at Sesmarias
Source: The Critical Investor��(10/7/21)
Avrupa Minerals is getting closer to solving the Sesmarias puzzle in Portugal, and the Critical Investor wants to know all about its exploration strategy. More >

Live-Stream Entertainment Shopping Company OOOOO Seals Deal With TikTok
Source: Streetwise Reports��(10/6/21)
Shopping meets entertainment meets community in the latest form of online commerce, which just received a lift through its partnership with TikTok. More >

Blue Sky Implements Second Strategy to Advance Uranium District in Argentina
Source: Streetwise Reports��(10/6/21)
With two goals, to identify new mineralized deposits at Amarillo Grande and to expand the resource at the project's Ivana deposit, Blue Sky Uranium is carrying out two concurrent drill programs. More >

Reliq's Telemedicine Platform Helps Free Up Hospital Space for COVID-19 Delta Patients
Source: Streetwise Reports��(10/6/21)
Simultaneously, demand is growing for Reliq Health's iUGO Care software as virtual healthcare delivery increases during the COVID-19 pandemic. More >

Silver Viper Seeks to ID High-Grade Silver at La Virginia in Mexico
Source: Streetwise Reports��(10/6/21)
Silver Viper aims to achieve this at La Virginia via a deep-penetrating geophysical survey of the El Rubi target. More >

Crimex Silver: Murder Most Foul
Source: Michael Ballanger for Streetwise Reports��(10/6/21)
Precious metals expert Michael Ballanger decries last week's manipulations in the silver market. More >

Voyager Shares Lift Off After Firm Signs License Deal With Pfizer for Next-Gen AAV Capsids for Gene Therapy Programs
Source: Streetwise Reports��(10/6/21)
Shares of Voyager Therapeutics Inc. traded 51% higher after the company reported it entered into a license and option agreement with Pfizer Inc. for two of its TRACERᵀᴹ AAV capsids that will be utilized to enhance Pfizer's neurologic and cardiovascular gene therapy programs. Voyager will receive an upfront payment of $30 million and is eligible to receive up to $600 million more plus product sales-based royalties, if all options are exercised and certain milestones are achieved. More >

SmileDirectClub Granted Patent for Mobile Oral Care Bus to Serve Remote Regions in the US & UK
Source: Streetwise Reports��(10/5/21)
SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K. More >

Cruise Industry Finally Shedding Delta Variant Concerns, Full Steam Ahead for 2022 Recovery
Source: McAlinden Research for Streetwise Reports��(10/5/21)
McAlinden Research Partners takes a look into the cruise ship industry and sees some calmer waters ahead. More >

Xenon Pharma Shares Gain 80% on Positive Data in Phase 2b Focal Epilepsy Trial
Source: Streetwise Reports��(10/4/21)
Shares of Xenon Pharmaceuticals Inc. soared to a new 52-week high after the company reported topline data from its Phase 2b X-TOLE clinical study demonstrating that its epilepsy drug candidate XEN1101 successfully met several primary and secondary efficacy endpoints and decreased monthly focal seizure frequency by 50% or greater from baseline. More >

Gold: Evergrande Investors' Savior
Source: Michael Ballanger for Streetwise Reports��(10/4/21)
Sector expert Michael Ballanger links debt and wolf packs in this exploration of the effects that the troubled Chinese company will have on gold. More >

Merck and Ridgeback Post Interim Data From Phase 3 Antiviral Drug Trial Showing 50% Reductions in Hospitalizations and Deaths in Mild and Moderate COV
Source: Streetwise Reports��(10/3/21)
Shares of Merck & Co. Inc. traded 9% higher after the company reported that in a global Phase 3 clinical trial conducted together with its partner Ridgeback Biotherapeutics, oral antiviral molnupiravir reduced risk of hospitalization or death by 50% versus placebo in patients with mild or moderate COVID-19. Merck plans to submit an Emergency Use Authorization application to the U.S. FDA and if authorized it would make molnupiravir the first approved oral antiviral medicine for COVID-19. More >

Argentina Lithium Enters Deal to Acquire More Lithium Exploration Assets: Lithium Product Prices Closing in at All-Time Highs
Source: The Critical Investor��(10/3/21)
Argentina Lithium is in the process of revitalizing its business, and right on time as lithium product prices are going through the roof these days. More >

Gold Terra Hits 4.57m @ 11.2g/t Gold at Yellorex Gold Zone Along Campbell Shear Structure
Source: The Critical Investor��(10/3/21)
The Critical Investor catches up with Gold Terra management about the first results of their Phase 2 drill program at the Yellorex target at the Campbell Shear, part of their Yellowknife City Gold project in Northwest Territories, Canada. More >

Renewable Power Plant Developer to Miss YE21 Guidance, Analyst Says Time for Investors to Sell
Source: Streetwise Reports��(10/2/21)
Several external factors have hampered Scatec's ability to deliver projects in its backlog, a problem discussed in a Pareto Securities report. More >

Vancouver Exploration Company Achieves Milestone at Gold Project in the Abitibi, Releases Mineral Resource Estimate
Source: Streetwise Reports��(10/1/21)
Gatling Exploration completed metallurgical tests on its three deposits at Larder, which provided initial gold recovery levels on which the company aims to improve. More >

Coverage Initiated on Nanomedicine Firm, Upside 'Potentially Significant' With Upcoming Trial Results
Source: Streetwise Reports��(10/1/21)
"With Clene's potential to realize several multibillion-dollar revenue opportunities, we see its roughly $480 million enterprise value as offering attractive risk-reward," an Oppenheimer report noted. More >

Canadian Explorer-Developer Appoints Its Chief Geologist as President
Source: Streetwise Reports��(9/30/21)
Brian May, the newest addition to Triumph Gold's leadership team, is intimately familiar with the company's flagship Freegold Mountain project, given his extensive involvement in recent exploration work there. More >

Will This Canadian REE Company Decide to Advance Its Athabascan Uranium Projects?
Source: Streetwise Reports��(9/30/21)
Defense Metals intends to determine if restarting exploration work at Geiger North and Klaproth will increase the value it is currently creating for shareholders. More >

Alzamend Shares Rise After FDA Gives Positive Response to Pre-IND Filing for Immune-Boosting Alzheimer's Vaccine
Source: Streetwise Reports��(9/30/21)
Shares of Alzamend Neuro Inc. traded 36% higher after the company reported that the U.S. FDA responded favorably to its Pre-IND application for AL002, a cell-based therapeutic vaccine designed to restore patients' immunological systems, providing them with the ability to combat Alzheimer's Disease. The FDA has granted the firm approval to initiate a combined Phase 1/2 clinical trial in Q1/22.

More >

COVID-19 Vaccine Could Be Approved in Q4/21 for 5 to 11 Year Olds
Source: Streetwise Reports��(9/30/21)
"Label extension for BioNTech and Pfizer's Comirnaty [vaccine] to include use in these younger individuals ought to buoy revenue growth near term," noted an H.C. Wainwright & Co. report. More >

Norseman Silver Finds Mineralization of 240 g/t Silver Over 7.5-Meter Run
Source: Streetwise Reports��(9/29/21)
“Dominant” silver projects led by experienced, local teams in mining-friendly jurisdiction and proven locations are the foundation for Norseman Silver’s plans for the next 12 months. More >

New Drill Results From B.C. Project Bode Well for Imminent Resource Estimate, Stock Rerating
Source: Streetwise Reports��(9/29/21)
Westhaven Gold's 2021 exploration and resource drilling at its Shovelnose property resumes after wildfires halted the project temporarily this summer, continues to bear positive results this autumn. More >

Biopharma Expands Clinical Program of Lead Drug Candidate to Treat Chronic Cough
Source: Streetwise Reports��(9/29/21)
Algernon Pharmaceuticals will now pursue Ifenprodil in chronic cough based on encouraging recent study results in a Phase 2 trial. More >

Dollar Tree to Offer High-Value, Multi-Price Products in Its Combo and Dollar Tree Plus Stores
Source: Streetwise Reports��(9/29/21)
Shares of Dollar Tree Inc. traded 16% higher after the company reported it is expanding the offerings and pricing of items in its stores to more than one dollar due to recent successful market test results at its newly formatted Combo and Dollar Tree Plus stores. The firm also announced that its Board of Directors has raised authorized share repurchases to US$2.5 billion. More >